BIOSYNEX (ALBIO.PA) Stock Income Statement
Europe - Euronext Paris - EPA:ALBIO - FR0011005933 - Common Stock
0.59 EUR
0 (-0.67%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 97.95M | 101.17M | 92.98M | 196.60M | 382.50M | |||
| Minority Interest Expense | -50.00K | 60.00K | -180.00K | 0.00 | N/A | |||
| Cost Of Goods | 40.00M | 44.00M | 44.00M | 94.30M | 176.10M | |||
| Gross Profit | 57.61M | 57.42M | 49.13M | 102.30M | 206.40M | |||
| Operating Expenses | 121.84M | 93.47M | 86.28M | 63.40M | 65.80M | |||
| Selling, General, and Administrative Expenses | 37.00M | 42.00M | 37.00M | 57.00M | 58.10M | |||
| Operating Income | -63.84M | -36.47M | -37.28M | 38.80M | 140.60M | |||
| Interest Income/Expense | -5.57M | -3.03M | -2.08M | -400.00K | -300.00K | |||
| Other Income/Expense | N/A | -3.19M | -980.00K | -2.80M | 400.00K | |||
| Non Recurring Items | -1.16M | -1.53M | 2.28M | -5.90M | -1.00M | |||
| Income Before Taxes | -74.00M | -45.00M | -38.00M | 29.80M | 139.60M | |||
| Income Tax | -3.36M | -1.36M | -2.56M | 8.60M | 32.90M | |||
| Net Income | -71.00M | -43.00M | -37.00M | 15.60M | 104.00M | |||
| EBITDA | -4.96M | -15.47M | -24.28M | 65.70M | 142.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.28 | -3.30 | -2.84 | 1.52 | 9.36 | |||
| Statistics | ||||||||
| Gross Profit Margin | 58.82% | 56.76% | 52.84% | 52.03% | 53.96% | |||
| Profit Margin | -72.48% | -42.50% | -39.79% | 7.93% | 27.19% | |||
| Operating Profit Margin | -65.17% | -36.05% | -40.10% | 19.74% | 36.76% | |||
All data in EUR